LBO France

LBO France, established in 1985, is a pioneering private equity firm headquartered in Paris, France. It specializes in middle market and small cap buyouts, real estate investments, and secondary debt purchases. The firm focuses on acquiring majority stakes in French companies, with a particular interest in subsidiaries of major groups or family-owned businesses across various sectors such as energy, healthcare, consumer goods, and real estate. LBO France invests between €2 million and €2 billion, targeting companies with enterprise values between €16 million and €2.5 billion, sales values between €50 million and €1 billion, and EBITDA between €5 million and €113.97 million. It typically seeks to exit investments within three to seven years and actively participates in the strategic management of its portfolio companies through seats on their supervisory boards.

Franck Abadia

Managing Director, Operating Team

Marie-Astrid Auriol

CFO, Partner and Board Member

Arthur Balland

Investment Director, LBO Small Cap

Xavier Bayrou

Investment Manager, LBO Mid Cap

Vincent Briancon

Partner, Mid Cap

Charles Béal

Investment Manager, LBO Small Cap

Giulio Carminati

Investment Manager, LBO Small Cap

Etienne Colas Ph.D

Senior Managing Director, Operating Team

Simon Couturier

Senior Director, LBO Mid Cap

Roberto D'Angelo

Managing Director, Country Manager

Robert Daussun Ph.D

Executive Chairman

Lucrezia Eruli

Investment Analyst, LBO Small Cap

Emmanuel Fiorentino

Senior Director, LBO Small Cap

Eva Hoël

Managing Director, LBO Mid Cap

Xavier Lefèvre

Managing Director

Neyla Merheb

Investment Director, Venture Digital Health

Franck Noiret

Managing Director, Venture Digital Health

Laura Panquet

Investment Director, Proptech

Matthes Seeling

Director, Venture Digital Health

Melissa Settouf

Investment Manager, LBO Mid Cap

Frédéric Teboul

CFO, Venture Digital Health

Pietro Zerauschek

Managing Director, Energy Infrastructure

Past deals in CEMAC

Meditect

Seed Round in 2021
Meditect is a social enterprise focused on enhancing the medicine supply chain in sub-Saharan Africa through innovative digital solutions. Operating in Côte d'Ivoire, Senegal, and Cameroon, the company aims to address the challenges of accessing quality medicines amidst a rapidly growing population. Meditect develops AI and blockchain-based software designed to track falsified medicines and improve the distribution of pharmaceuticals. By enabling pharmacists to verify the authenticity of medicines, the company strengthens the legal distribution network and combats the sale of counterfeit products, ultimately improving healthcare outcomes in developing countries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.